Nomura Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16M Buy
17,421
+10,885
+167% +$11M 0.04% 307
2025
Q4
$7.02M Sell
6,536
-105,885
-94% -$101M 0.01% 670
2025
Q3
$85.8M Buy
112,421
+73,515
+189% +$54.7M 0.13% 109
2025
Q2
$30.3M Sell
38,906
-9,402
-19% -$7.31M 0.06% 188
2025
Q1
$39.9M Sell
48,308
-4,358
-8% -$3.63M 0.07% 174
2024
Q4
$40.7M Buy
52,666
+22,525
+75% +$18.7M 0.05% 186
2024
Q3
$26.7M Sell
30,141
-16,222
-35% -$14.6M 0.06% 206
2024
Q2
$42M Buy
46,363
+21,162
+84% +$16.9M 0.08% 141
2024
Q1
$19.6M Buy
25,201
+9,463
+60% +$6.73M 0.05% 270
2023
Q4
$9.17M Buy
15,738
+10,863
+223% +$6.34M 0.02% 474
2023
Q3
$2.62M Sell
4,875
-10,012
-67% -$5.16M 0.01% 719
2023
Q2
$6.98M Buy
14,887
+12,489
+521% +$5.24M 0.02% 416
2023
Q1
$824K Sell
2,398
-11,464
-83% -$3.87M ﹤0.01% 1051
2022
Q4
$5.07M Sell
13,862
-14,260
-51% -$5.06M 0.02% 490
2022
Q3
$9.1M Buy
+28,122
New +$8.91M 0.04% 372
2022
Q1
Sell
-11,741
Closed -$3.24M 2227
2021
Q4
$3.24M Sell
11,741
-7,253
-38% -$1.84M 0.01% 846
2021
Q3
$4.36M Buy
18,994
+10,686
+129% +$2.64M 0.01% 663
2021
Q2
$1.91M Buy
8,308
+4,938
+147% +$992K ﹤0.01% 884
2021
Q1
$629K Sell
3,370
-25,345
-88% -$4.96M ﹤0.01% 1271
2020
Q4
$4.85M Sell
28,715
-86,970
-75% -$13M 0.01% 582
2020
Q3
$17.1M Buy
115,685
+98,171
+561% +$15.2M 0.04% 258
2020
Q2
$2.88M Buy
17,514
+4,546
+35% +$698K 0.01% 491
2020
Q1
$1.8M Sell
12,968
-16,121
-55% -$2.22M 0.01% 483
2019
Q4
$3.82M Buy
29,089
+27,063
+1,336% +$3.14M 0.01% 495
2019
Q3
$224K Sell
2,026
-898
-31% -$100K ﹤0.01% 1071
2019
Q2
$329K Buy
2,924
+111
+4% +$13.1K ﹤0.01% 993
2019
Q1
$363K Sell
2,813
-49,859
-95% -$6.06M ﹤0.01% 963
2018
Q4
$6.09M Buy
52,672
+14,325
+37% +$1.6M 0.02% 448
2018
Q3
$4.13M Buy
38,347
+14,888
+63% +$1.49M 0.01% 532
2018
Q2
$2M Sell
23,459
-71,979
-75% -$5.91M 0.01% 720
2018
Q1
$7.38K Buy
95,438
+19,807
+26% +$1.59M 0.01% 470
2017
Q4
$6.39M Buy
75,631
+26,086
+53% +$2.22M 0.01% 559
2017
Q3
$4.24M Sell
49,545
-79,105
-61% -$6.49M 0.01% 593
2017
Q2
$10.6M Buy
128,650
+121,537
+1,709% +$9.92M 0.03% 355
2017
Q1
$598K Sell
7,113
-82,871
-92% -$6.64M ﹤0.01% 867
2016
Q4
$6.62M Buy
89,984
+19,141
+27% +$1.43M 0.02% 474
2016
Q3
$5.67M Buy
+70,843
New +$5.67M 0.02% 405
2016
Q2
Sell
-8,882
Closed -$640K 1445
2016
Q1
$640K Sell
8,882
-3
-0% -$227 ﹤0.01% 808
2015
Q4
$750K Sell
8,885
-802
-8% -$66.6K ﹤0.01% 890
2015
Q3
$793K Sell
9,687
-76,822
-89% -$6.49M ﹤0.01% 815
2015
Q2
$7.07M Buy
86,509
+70,123
+428% +$5.34M 0.02% 342
2015
Q1
$1.18M Sell
16,386
-107,987
-87% -$7.69M ﹤0.01% 774
2014
Q4
$8.5M Buy
124,373
+50,423
+68% +$3.4M 0.02% 415
2014
Q3
$4.77M Buy
73,950
+16,683
+29% +$1.06M 0.01% 715
2014
Q2
$3.55M Sell
57,267
-467,557
-89% -$27.9M ﹤0.01% 828
2014
Q1
$30.8M Buy
524,824
+428,369
+444% +$23.9M 0.01% 206
2013
Q4
$4.92M Sell
96,455
-151,448
-61% -$7.58M 0.02% 406
2013
Q3
$12.5M Buy
247,903
+83,337
+51% +$4.36M 0.08% 211
2013
Q2
$8.09M Buy
+164,566
New +$8.95M 0.07% 209

Other funds holding LLY

Nomura Holdings's LLY Position: Q1 2026 in Review

Nomura Holdings increased its Eli Lilly (LLY) stake by 167% in Q1 2026, buying an estimated $11M and bringing the position to 17,421 shares worth $16M. The position accounts for 0.04% of the portfolio, ranked #307.

Nomura Holdings first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $85.8M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Nomura Holdings held 17,421 shares of Eli Lilly worth $16M as of Q1 2026.
  • Nomura Holdings bought 10,885 Eli Lilly shares in Q1 2026, an estimated $11M.
  • Eli Lilly made up 0.04% of Nomura Holdings's portfolio in Q1 2026, its #307 holding.
  • Nomura Holdings first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Nomura Holdings's Eli Lilly position peaked at $85.8M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.